SunTrust Starts OPTR, ACAD, PCYC, TSRX, FURX, PYBI at Buy, ARQL at Neutral
Tweet Send to a FriendGet Alerts OPTR Hot Sheet
Price: $14.25 -0.9%
Rating Summary:
5 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
5 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade OPTR Now!
An analyst at SunTrust Robinson Humphrey initiated coverage on several Biotech stocks Friday morning:
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
- Optimer Pharma (Nasdaq: OPTR) with a Buy rating and a $20 price target
- ACADIA Pharma (Nasdaq: ACAD) with a Buy rating and a $6 price target
- Pharmacyclics (Nasdaq: PCYC) with a Buy rating and a $48 price target
- Trius Therapeutics (Nasdaq: TSRX) with a Buy rating and a $13 price target
- Furiex Pharma (Nasdaq: FURX) with a Buy rating and a $35 price target
- Puma Biotech (OTC: PYBI) with a Buy rating and a $19 price target
- ArQule (Nasdaq: ARQL) with a Neutral rating
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Atmel (ATML) at Buy
- Maxim Group Starts Cullen/Frost Bankers (CFR) at Buy
- Topeka Capital Starts NVIDIA (NVDA) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreyLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

